Journal of Pharmacy And Bioallied Sciences

REVIEW ARTICLE
Year
: 2021  |  Volume : 13  |  Issue : 2  |  Page : 163--171

A narrative review of antiviral drugs used for COVID-19 pharmacotherapy


Subodh Kumar1, Manoj K Saurabh1, Vikas Maharshi1, Dibyajyoti Saikia2 
1 Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), Deoghar, Jharkhand, India
2 Department of Pharmacology, Kanti Devi Medical College Hospital and Research Center (KDMCH&RC), Mathura, Uttar Pradesh, India

Correspondence Address:
Dr. Manoj K Saurabh
Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), Deoghar 814152, Jharkhand
India

Purpose: A number of research articles has been published evaluating safety and efficacy of drugs against COVID-19. This study was undertaken to collate and review the information regarding common proposed anti- viral drugs for easy reference. Methods: The literature was search was done using terms like severe acute respiratory syndrome or SARS-CoV-2 or 2019-nCoV or SARS-CoV or COVID-19 in combination with drugs or treatment or pharmaco-therapy using PubMed and google scholar to identify relevant articles. Results: Despite showing good early results, hydroxychloroquine and lopinavir-ritonavir has not shown clinical benefit in randomized controlled trials. However lopinavir in combination with other drugs specially interferon is being investigated. Remdesivir has shown positive effect in terms of clinical improvement and continued to being investigated alone or in combination with other drugs. Favipiravir has shown mixed results and more data from adequately powered study is needed to prove its efficacy. Conclusions: Many drugs which showed positive effect in initial studies could not replicate the same benefit in large randomized controlled trials. There is need to evaluate efficacy and safety of drugs based on high quality evidence before allowing it to be used in general population.


How to cite this article:
Kumar S, Saurabh MK, Maharshi V, Saikia D. A narrative review of antiviral drugs used for COVID-19 pharmacotherapy.J Pharm Bioall Sci 2021;13:163-171


How to cite this URL:
Kumar S, Saurabh MK, Maharshi V, Saikia D. A narrative review of antiviral drugs used for COVID-19 pharmacotherapy. J Pharm Bioall Sci [serial online] 2021 [cited 2021 Oct 24 ];13:163-171
Available from: https://www.jpbsonline.org/article.asp?issn=0975-7406;year=2021;volume=13;issue=2;spage=163;epage=171;aulast=Kumar;type=0